Chiari type 1 malformation in an infant with type 2 Pfeiffer syndrome: further evidence of acquired pathogenesis

Adrianna Ranger1, Ali Al-Hayek, Damir Matic

  • 1Pediatric Neurosurgery, Department of Clinical Neurological Sciences, Children's Hospital London Health Sciences Center, London, Ontario, Canada. aranger@uwo.ca

Insights

Type 2 Pfeiffer syndrome, a craniosynostosis, is linked to Chiari malformation (CM). This case shows CM can be acquired, not just congenital, in these patients due to skull and brain growth issues.

Area of Science:

  • Pediatric Neurosurgery
  • Craniofacial Surgery
  • Medical Genetics

Background:

  • Type 1 Chiari malformation (CM) is associated with some congenital craniosynostosis syndromes.
  • Type 2 Pfeiffer syndrome involves premature cranial suture fusion, cloverleaf skull, ptosis, limb abnormalities, and FGFR mutations.
  • Severe neurologic and cognitive defects are common in Type 2 Pfeiffer syndrome, leading to high early mortality.

Observation:

  • A term male infant with Type 2 Pfeiffer syndrome initially showed no CM on brain imaging at 2 months.
  • Repeated imaging at 4 months revealed clear evidence of CM, despite prior reconstructive craniotomies and shunt insertion.
  • Posterior fossa decompression was performed and resulted in a good outcome.

Findings:

  • This case supports the concept of acquired tonsillar herniation in craniosynostosis syndromes.
  • The etiology of acquired CM appears multifactorial, including skull-brain growth disproportion, impaired venous drainage, hydrocephalus, and elevated intracranial pressure.
  • Congenital deficiencies in fibroblast growth factor receptors contribute to skull growth issues.

Implications:

  • Understanding acquired CM in craniosynostosis is crucial for managing these complex pediatric cases.
  • Early recognition and intervention for acquired CM may improve neurological outcomes.
  • Further research into the multifactorial etiology can guide therapeutic strategies for craniosynostosis patients.

Related Concept Videos

Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Increased Intracranial Pressure ll: Pathophysiology01:29

Increased Intracranial Pressure ll: Pathophysiology

Increased intracranial pressure (ICP) refers to a potentially life-threatening rise in pressure inside the skull. This usually happens when there is a major change in the volume of brain tissue, blood, or cerebrospinal fluid (CSF) — the three components inside the skull. According to the Monro-Kellie doctrine, if the volume of one component increases, the volumes of the other components must decrease to maintain normal pressure. If this does not happen, ICP rises.The process often begins with...
Secondary Spinal Cord Injury llI: Pathophysiology01:25

Secondary Spinal Cord Injury llI: Pathophysiology

Early Ischemia and Ionic ImbalanceWithin minutes of spinal cord injury, a secondary cascade begins, progressing over hours to weeks. Vascular damage reduces blood flow, causing ischemia and mitochondrial dysfunction. ATP depletion leads to ion pump failure, membrane depolarization, sodium influx, potassium efflux, and water accumulation, resulting in cellular swelling. Increased intracellular calcium further disrupts mitochondria and accelerates cellular injury.Excitotoxicity and Neuronal...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Neurulation01:30

Neurulation

Neurulation is the embryological process which forms the precursors of the central nervous system and occurs after gastrulation has established the three primary cell layers of the embryo: ectoderm, mesoderm, and endoderm. In humans, the majority of this system is formed via primary neurulation, in which the central portion of the ectoderm—originally appearing as a flat sheet of cells—folds upwards and inwards, sealing off to form a hollow neural tube. As development proceeds, the anterior...
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...